Vimarsana
Biggest News Aggregation in the World

Page 26 - Sera Prognostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sera Prognostics Today - Breaking & Trending Today

Proteomics Goes Public in 2021 - Vimarsana News

Proteomics Goes Public in 2021

Seven proteomics firms, ranging from tools companies to diagnostics outfits, listed on public markets in 2021 in a sign of growing interest in the space.

SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX - Vimarsana News

SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth - Vimarsana News

Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations - Vimarsana News

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations - Vimarsana News

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...